SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012331
Filing Date
2022-08-05
Accepted
2022-08-04 21:45:34
Documents
81
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ntra-20220630x10q.htm   iXBRL 10-Q 2608837
2 EX-10.1 ntra-20220630xex10d1.htm EX-10.1 58304
3 EX-31.1 ntra-20220630xex31d1.htm EX-31.1 13854
4 EX-31.2 ntra-20220630xex31d2.htm EX-31.2 14983
5 EX-32.1 ntra-20220630xex32d1.htm EX-32.1 10373
6 EX-32.2 ntra-20220630xex32d2.htm EX-32.2 10656
  Complete submission text file 0001558370-22-012331.txt   11808201

Data Files

Seq Description Document Type Size
7 EX-101.SCH ntra-20220630.xsd EX-101.SCH 60078
8 EX-101.CAL ntra-20220630_cal.xml EX-101.CAL 65444
9 EX-101.DEF ntra-20220630_def.xml EX-101.DEF 319416
10 EX-101.LAB ntra-20220630_lab.xml EX-101.LAB 600904
11 EX-101.PRE ntra-20220630_pre.xml EX-101.PRE 479377
75 EXTRACTED XBRL INSTANCE DOCUMENT ntra-20220630x10q_htm.xml XML 2660306
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

IRS No.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37478 | Film No.: 221138397
SIC: 8071 Services-Medical Laboratories